ESMO Webinar: Advanced Gastric Cancer 2025

Login to get immediate access to this content.

Login

Programme

• 12 March 2025

Introduction and Welcome

Filippo Pietrantonio

Navigating the therapeutic landscape & exploring unmet needs in advanced gastric cancer

Sylvie Lorenzen

Optimal biomarker workup for patients with advanced gastric cancer: diagnosis, prognostication, and personalised treatment

Filippo Pietrantonio

Preventing and managing adverse events in patients with advanced gastric cancer in the era of precision oncology

Tanja Fleitas Kanonnikoff

Live discussion, Q&A and Conclusions

All speakers

• 

  Filippo Pietrantonio

  Chair

  GI Medical Oncologist at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
• 

  Sylvie Lorenzen

  Speaker

  Klinikum rechts der Isar
  Department of Hematology and Oncology
  Technical University Munich
• 

  Tania Fleitas Kanonnikoff

  Speaker

  University Hospital of Valencia, INCLIVA
  

Description

The webinar started with a short welcome and introduction, followed by a lecture on navigating the therapeutic landscape & exploring unmet needs in advanced gastric cancer. There was then a presentation on optimal biomarker workup for patients with advanced gastric cancer, covering diagnosis, prognostication, and personalized treatment. The last lecture focused on preventing and managing adverse events in patients with advanced gastric cancer in the era of precision oncology. The webinar concluded with a live Q&A and discussion.

Learning objectives

• Improving treatment decisions for gastric cancer in the rapidly evolving treatment landscape.
• Improving identification and differentiation of key biomarkers in gastric cancer and understanding their impact on diagnosis, personalised treatment, and clinical outcomes.
• Improving awareness of potential adverse events associated with current and emerging gastric cancer treatments.